Meredith Cummins
Overview
Explore the profile of Meredith Cummins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
1
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loree J, Chan D, Lim J, Stuart H, Fidelman N, Koea J, et al.
JAMA Oncol
. 2024 Oct;
10(12):1707-1720.
PMID: 39361298
Importance: Evidence-based treatment decisions for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) require individualized patient-centered decision-making that accounts for patient and cancer characteristics. Objective: To create an accessible guidance document to educate...
2.
Real-world management and patient perspectives on QOL with neuroendocrine tumors: An ANZ perspective
Michael M, Chantrill L, Price T, Chan D, Wakelin K, Cummins M
Asia Pac J Clin Oncol
. 2021 Apr;
17 Suppl 2:3-10.
PMID: 33851520
No abstract available.
3.
Willenberg V, Bamblett M, Cummins M, Hoberg D
Aust Nurs Midwifery J
. 2017 Dec;
22(6):30-3.
PMID: 29236425
The SHINE home injection service is part of a patient support program run by Novartis. SHINE is for people prescribed octreotide long-acting release (Sandostatin LAR) for neuroendocrine tumours (NETs) and...
4.
Cummins M, Pavlakis N
Ther Adv Med Oncol
. 2013 Sep;
5(5):286-300.
PMID: 23997829
Together with the use of novel oral targeted therapies, a multidisciplinary approach can be used to effectively treat patients with advanced pancreatic neuroendocrine tumours (pNETs). Here we review the integration...